stock upgrade
Cowen Upgrades PerkinElmer Stock to Outperform
Analyst Max Masucci said the firm is expected to generate at least $3.21 billion in COVID-19-related revenues, while he lowered the stock price target to $164 per share.
Illumina, Belgium Genetic Centers Partner on WGS-Based Diagnostics; Evercore Upgrades Illumina Shares
The San Diego-based sequencing technology firm is also launching noninvasive prenatal genetic testing on the VeriSeq v2 platform in Thailand.
Illumina Upgraded to Overweight by Piper Sandler
In a note to investors, Piper Sandler analysts wrote that the upgrade reflects increased confidence in Grail and Illumina's core next-generation sequencing business.
Hologic Upgraded to Outperform by Cowen on Expected Coronavirus Test Demand
Cowen said that Hologic is on track to more than double its Panther system placements to about 500 this year, driven by SARS-CoV-2 test demand.
William Blair Upgrades Meridian Bioscience to Outperform
Meridian has been providing essential components, including reagents, for multiple SARS-CoV-2 molecular and serology tests.
Jan 4, 2019
Cowen Upgrades Myriad Genetics Stock
Jun 1, 2018
Leerink Upgrades T2 Biosystems to To Outperform
Mar 8, 2018
Raymond James Upgrades Quidel to Strong Buy
Dec 11, 2017
Cowen Upgrades Hologic to Outperform
Apr 21, 2017
Raymond James Upgrades Quest to Outperform
Mar 7, 2017
Janney Upgrades Foundation Medicine to Neutral
Sep 19, 2016